Sotera Health (NASDAQ:SHC) Insider Sells $2,826,000.00 in Stock

Key Points

• Insider sale: Sotera Health insider Michael Rutz sold 150,000 shares for approximately $2.83 million at an average price of $18.84, reducing his position by 30.97%.
• Strong quarterly results: The company reported quarterly EPS of $0.26, beating estimates by $0.02, while revenue rose 9.2% year over year to $321.38 million.
• Positive analyst sentiment: Analysts raised several price targets, with the stock carrying a consensus “Moderate Buy” rating and a $21.50 average target versus its recent price of $19.11.

Sotera Health Company (NASDAQ:SHC - Get Free Report) insider Michael Rutz sold 150,000 shares of the firm's stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $18.84, for a total value of $2,826,000.00. Following the transaction, the insider owned 334,279 shares in the company, valued at approximately $6,297,816.36. This trade represents a 30.97% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Sotera Health Trading Up 0.7%

NASDAQ SHC traded up $0.14 during trading on Tuesday, reaching $19.11. 3,706,496 shares of the stock traded hands, compared to its average volume of 2,891,297. The stock's 50-day moving average price is $17.20 and its 200 day moving average price is $16.31. The firm has a market cap of $5.45 billion, a price-to-earnings ratio of 33.53 and a beta of 1.77. Sotera Health Company has a fifty-two week low of $13.09 and a fifty-two week high of $19.85. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.24 by $0.02. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The business had revenue of $321.38 million during the quarter, compared to analysts' expectations of $309.70 million. During the same quarter in the prior year, the company earned $0.20 EPS. The firm's quarterly revenue was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Analysts predict that Sotera Health Company will post 0.87 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently commented on SHC shares. Citigroup boosted their price target on Sotera Health from $23.00 to $25.00 and gave the company a "buy" rating in a report on Friday. Weiss Ratings upgraded shares of Sotera Health from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, July 9th. Piper Sandler reiterated an "overweight" rating and set a $25.00 target price (up from $22.00) on shares of Sotera Health in a research note on Friday. The Goldman Sachs Group began coverage on shares of Sotera Health in a report on Friday, June 5th. They set a "buy" rating and a $20.00 target price for the company. Finally, Barclays boosted their price target on Sotera Health from $19.00 to $22.00 and gave the company an "overweight" rating in a research note on Friday. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, Sotera Health has a consensus rating of "Moderate Buy" and a consensus price target of $21.50.

Institutional Trading of Sotera Health

A number of institutional investors and hedge funds have recently made changes to their positions in SHC. BlackRock Inc. bought a new position in Sotera Health in the second quarter valued at approximately $428,635,000. Sculptor Capital LP lifted its position in shares of Sotera Health by 57.4% during the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company's stock worth $370,440,000 after buying an additional 7,658,200 shares during the last quarter. Sachem Head Capital Management LP lifted its position in shares of Sotera Health by 47.2% during the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company's stock worth $205,418,000 after buying an additional 3,735,000 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Sotera Health by 16.7% in the fourth quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company's stock worth $339,189,000 after acquiring an additional 2,756,583 shares during the last quarter. Finally, AQR Capital Management LLC boosted its stake in shares of Sotera Health by 1,206.2% in the 4th quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company's stock valued at $50,523,000 after purchasing an additional 2,644,831 shares in the last quarter. Institutional investors own 91.03% of the company's stock.

About Sotera Health

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source